Suppr超能文献

撒哈拉以南非洲地区卫生系统的准备情况及直肠青蒿琥酯用于重症疟疾的实施:真实成本与制约因素分析

Health system readiness and the implementation of rectal artesunate for severe malaria in sub-Saharan Africa: an analysis of real-world costs and constraints.

作者信息

Lambiris Mark J, Venga Guy Ndongala, Ssempala Richard, Balogun Victor, Galactionova Katya, Musiitwa Michael, Kagwire Fred, Olosunde Oluseyi, Emedo Emmanel, Luketa Sylvie, Sangare Moulaye, Buj Valentina, Delvento Giulia, Tshefu Antoinette, Okitawutshu Jean, Omoluabi Elizabeth, Awor Phyllis, Signorell Aita, Hetzel Manuel W, Lee Tristan T, Brunner Nina C, Cereghetti Nadja, Visser Theodoor, Napier Harriet G, Burri Christian, Lengeler Christian

机构信息

Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.

Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

出版信息

Lancet Glob Health. 2023 Feb;11(2):e256-e264. doi: 10.1016/S2214-109X(22)00507-1. Epub 2022 Dec 21.

Abstract

BACKGROUND

Rectal artesunate, an efficacious pre-referral treatment for severe malaria in children, was deployed at scale in Uganda, Nigeria, and DR Congo. In addition to distributing rectal artesunate, implementation required additional investments in crucial but neglected components in the care for severe malaria. We examined the real-world costs and constraints to rectal artesunate implementation.

METHODS

We collected primary data on baseline health system constraints and subsequent rectal artesunate implementation expenditures. We calculated the equivalent annual cost of rectal artesunate implementation per child younger than 5 years at risk of severe malaria, from a health system perspective, separating neglected routine health system components from incremental costs of rectal artesunate introduction.

FINDINGS

The largest baseline constraints were irregular health worker supervisions, inadequate referral facility worker training, and inadequate malaria commodity supplies. Health worker training and behaviour change campaigns were the largest startup costs, while supervision and supply chain management accounted for most annual routine costs. The equivalent annual costs of preparing the health system for managing severe malaria with rectal artesunate were US$2·63, $2·20, and $4·19 per child at risk and $322, $219, and $464 per child treated in Uganda, Nigeria, and DR Congo, respectively. Strengthening the neglected, routine health system components accounted for the majority of these costs at 71·5%, 65·4%, and 76·4% of per-child costs, respectively. Incremental rectal artesunate costs accounted for the minority remainder.

INTERPRETATION

Although rectal artesunate has been touted as a cost-effective pre-referral treatment for severe malaria in children, its real-world potential is limited by weak and under-financed health system components. Scaling up rectal artesunate or other interventions relying on community health-care providers only makes sense alongside additional, essential health system investments sustained over the long term.

FUNDING

Unitaid.

TRANSLATION

For the French translation of the abstract see Supplementary Materials section.

摘要

背景

青蒿琥酯直肠给药是一种治疗儿童重症疟疾的有效转诊前治疗方法,已在乌干达、尼日利亚和刚果民主共和国大规模推广。除了分发青蒿琥酯直肠给药制剂外,实施该方法还需要在重症疟疾护理中对关键但被忽视的环节进行额外投资。我们研究了青蒿琥酯直肠给药实施的实际成本和制约因素。

方法

我们收集了关于基线卫生系统制约因素和随后青蒿琥酯直肠给药实施支出的原始数据。从卫生系统的角度,我们计算了每一名有重症疟疾风险的5岁以下儿童青蒿琥酯直肠给药实施的等效年度成本,将被忽视的常规卫生系统组成部分与引入青蒿琥酯直肠给药的增量成本区分开来。

研究结果

最大的基线制约因素是卫生工作者监督不规律、转诊设施工作人员培训不足以及疟疾商品供应不足。卫生工作者培训和行为改变宣传活动是最大的启动成本,而监督和供应链管理占大多数年度常规成本。在乌干达、尼日利亚和刚果民主共和国,为使用青蒿琥酯直肠给药管理重症疟疾而准备卫生系统的等效年度成本分别为每名有风险儿童2.63美元、2.20美元和4.19美元,以及每名接受治疗儿童322美元、219美元和464美元。加强被忽视的常规卫生系统组成部分分别占这些成本的大部分,分别为每名儿童成本的71.5%、65.4%和76.4%。青蒿琥酯直肠给药的增量成本占其余的少数部分。

解读

尽管青蒿琥酯直肠给药被吹捧为一种具有成本效益的儿童重症疟疾转诊前治疗方法,但其实际潜力受到薄弱且资金不足的卫生系统组成部分的限制。扩大青蒿琥酯直肠给药或其他依赖社区卫生保健提供者的干预措施,只有在长期持续进行额外的基本卫生系统投资的情况下才有意义。

资金来源

国际药品采购机制。

摘要的法语译文见补充材料部分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验